Heart Failure Case Study

/in /by

Ruth Olson, a 74 year old Caucasian, non-Hispanic female has a past medical history significant for hypothyroidism, urinary incontinence and was recently diagnosed with heart failure.   She takes levothyroxine once daily and Detrol twice daily.  She admits that she does not drink as much water as she should because of the urinary incontinence. 

You determine that Ruth is ACC/AHA Heart Failure Stage B.

Questions:

  1. What are the treatment goals for a patient with heart failure?
  2. What are non-pharmacologic treatment strategies for the management of heart failure?
  3. What pharmacologic treatment would you prescribe today (be sure to include, at a minimum, drug name, dose, route, frequency)? What other treatment options exist? Why did you choose your treatment option over other available options (if applicable)?
  4. What is the mechanism of action of your selected pharmacologic agent? How does the mechanism of action correlate with the physiology/pathophysiology of heart failure?
  5. What are the most common adverse effects?
  6. What is the cost of your selected treatment option?
  7. Discuss pharmacokinetics and pharmacodynamics of your selected pharmacologic agent (be sure to include, at a minimum, onset, peak, duration, half-life, etc).

*NB*

PLEASE SEPERATE THE REFERENCES. 1 1/2 PAGE PER CASE STUDY.

THANK YOU

 

Atrial Fibrillation Case Study

Irving Olson, a 75 year old non-Hispanic, Caucasian male was recently diagnosed with atrial fibrillation after presenting to the emergency room with syncope.  He will be following up with you in the office in a few days so you have requested his medical records from his hospitalization for atrial fibrillation. 

Questions:

  1. What are the treatment goals for a patient with atrial fibrillation?
  2. Using the information above, what is Irving’s CHA2-DS2-VASC Score? What does his score mean in regards to the management of his newly diagnosed atrial fibrillation?
  3. What are non-pharmacologic treatment strategies for the management of atrial fibrillation?
  4. What pharmacologic treatment would you expect Irving to be prescribed after discharge from the hospital with a diagnosis of atrial fibrillation (be sure to include, at a minimum, drug name, dose, route, frequency)? What other treatment options exist? Why did you choose your treatment option over other available options (if applicable)?
  5. What is the mechanism of action of your selected pharmacologic agent? How does the mechanism of action correlate with the physiology/pathophysiology of atrial fibrillation?
  6. What are the most common adverse effects?
  7. What is the cost of your selected treatment option?
  8. Discuss pharmacokinetics and pharmacodynamics of your selected pharmacologic agent (be sure to include, at a minimum, onset, peak, duration, half-life, etc).